Involvement_NN of_IN the_DT Matrix_NP and_CC Nucleocapsid_NP Domains_NP of_IN the_DT Bovine_NP Leukemia_NP Virus_NP Gag_NP Polyprotein_NP Precursor_NP in_IN Viral_NP RNA_NP Packaging_NP The_DT RNA_NP packaging_NN process_NN for_IN retroviruses_NNS involves_VBZ a_DT recognition_NN event_NN of_IN the_DT genome-length_NN viral_JJ RNA_NP by_IN the_DT viral_JJ Gag_NP polyprotein_NN precursor_NN (_( PrGag_NP )_) ,_, an_DT important_JJ step_NN in_IN particle_NN morphogenesis_NN ._SENT The_DT mechanism_NN underlying_VBG this_DT genome_NN recognition_NN event_NN for_IN most_JJS retroviruses_NNS is_VBZ thought_VBN to_TO involve_VB an_DT interaction_NN between_IN the_DT nucleocapsid_NN (_( NC_NP )_) domain_NN of_IN PrGag_NP and_CC stable_JJ RNA_NP secondary_JJ structures_NNS that_WDT form_VBP the_DT RNA_NP packaging_NN signal_NN ._SENT Presently_RB ,_, there_EX is_VBZ limited_JJ information_NN regarding_VBG PrGag-RNA_NP interactions_NNS involved_VBN in_IN RNA_NP packaging_NN for_IN the_DT deltaretroviruses_NNS ,_, which_WDT include_VBP bovine_JJ leukemia_NN virus_NN (_( BLV_NP )_) and_CC human_JJ T-cell_NN leukemia_NN virus_NN types_NNS 1_CD and_CC 2_CD (_( HTLV-1_NP and_CC -2_CD ,_, respectively_RB )_) ._SENT To_TO address_VB this_DT ,_, alanine-scanning_VBG mutagenesis_NN of_IN BLV_NP PrGag_NP was_VBD done_VBN with_IN a_DT virus-like_JJ particle_NN (_( VLP_NP )_) system_NN ._SENT As_IN predicted_VBN ,_, mutagenesis_NN of_IN conserved_VBN basic_JJ residues_NNS as_RB well_RB as_IN residues_NNS of_IN the_DT zinc_NN finger_NN domains_NNS in_IN the_DT BLV_NP NC_NP domain_NN of_IN PrGag_NP revealed_VBD residues_NNS that_WDT led_VBD to_TO a_DT reduction_NN in_IN viral_JJ RNA_NP packaging_NN ._SENT Interestingly_RB ,_, when_WRB conserved_VBN basic_JJ residues_NNS in_IN the_DT BLV_NP MA_NN domain_NN of_IN PrGag_NP were_VBD mutated_VBN to_TO alanine_NN or_CC glycine_NN ,_, but_CC not_RB when_WRB mutated_VBN to_TO another_DT basic_JJ residue_NN ,_, reductions_NNS in_IN viral_JJ RNA_NP packaging_NN were_VBD also_RB observed_VBN ._SENT The_DT ability_NN of_IN PrGag_NP to_TO be_VB targeted_VBN to_TO the_DT cell_NN membrane_NN was_VBD not_RB affected_VBN by_IN these_DT mutations_NNS in_IN MA_NN ,_, indicating_VBG that_IN PrGag_NP membrane_NN targeting_VBG was_VBD not_RB associated_VBN with_IN the_DT reduction_NN in_IN RNA_NP packaging_NN ._SENT These_DT observations_NNS indicate_VBP that_IN these_DT basic_JJ residues_NNS in_IN the_DT MA_JJ domain_NN of_IN PrGag_NP influence_NN RNA_NP packaging_NN ,_, without_IN influencing_VBG Gag_NP membrane_NN localization_NN ._SENT It_PP was_VBD further_RBR observed_VBN that_IN (_( i_NP )_) a_DT MA/NC_NP double_JJ mutant_NN had_VBD a_DT more_RBR severe_JJ RNA_NP packaging_NN defect_NN than_IN either_DT mutant_NN alone_RB ,_, and_CC (_( ii_NP )_) RNA_NP packaging_NN was_VBD not_RB found_VBN to_TO be_VB associated_VBN with_IN transient_JJ localization_NN of_IN Gag_NP in_IN the_DT nucleus_NN ._SENT In_IN summary_NN ,_, this_DT report_NN provides_VBZ the_DT first_JJ direct_JJ evidence_NN for_IN the_DT involvement_NN of_IN both_CC the_DT BLV_NP MA_NP and_CC NC_NP domains_NNS of_IN PrGag_NP in_IN viral_JJ RNA_NP packaging_NN ._SENT The_DT RNA_NP packaging_NN process_NN for_IN retroviruses_NNS involves_VBZ a_DT recognition_NN event_NN of_IN the_DT genome-length_NN viral_JJ RNA_NP by_IN the_DT viral_JJ Gag_NP polyprotein_NN precursor_NN (_( PrGag_NP )_) ,_, which_WDT acts_VBZ to_TO initiate_VB the_DT morphogenesis_NN of_IN virus_NN particles_NNS (_( see_VB reference_NN for_IN review_NN )_) ._SENT The_DT mechanism_NN underlying_VBG this_DT genome_NN recognition_NN event_NN is_VBZ poorly_RB understood_VBN ,_, but_CC many_JJ biochemical_JJ and_CC genetic_JJ analyses_NNS have_VBP revealed_VBN that_IN this_DT event_NN involves_VBZ the_DT interaction_NN between_IN stable_JJ RNA_NP secondary_JJ structures_NNS at_IN the_DT 5_CD '_POS end_NN of_IN the_DT viral_JJ genome_NN and_CC ,_, in_IN many_JJ cases_NNS ,_, amino_NN acids_NNS in_IN the_DT nucleocapsid_NN (_( NC_NP )_) domain_NN of_IN PrGag_NP ._SENT The_DT genome_NN recognition_NN event_NN is_VBZ an_DT important_JJ step_NN in_IN the_DT morphogenesis_NN of_IN infectious_JJ retrovirus_NN particles_NNS ._SENT This_DT recognition_NN event_NN leads_VBZ to_TO the_DT predominant_JJ packaging_NN (_( encapsidation_NN )_) of_IN the_DT genome-length_NN viral_JJ RNA_NP into_IN assembling_VBG particles_NNS ._SENT This_DT discrimination_NN process_NN ,_, which_WDT is_VBZ primarily_RB a_DT viral_JJ RNA-protein_NP interaction_NN ,_, is_VBZ known_VBN to_TO strongly_RB favor_VB the_DT full-length_JJ viral_JJ RNA_NP over_RB spliced_VBD viral_JJ RNAs_NP and_CC cellular_JJ mRNAs_NNS ._SENT In_IN general_NN ,_, the_DT RNA_NP sequences_NNS necessary_JJ and_CC sufficient_JJ for_IN the_DT RNA_NP packaging_NN process_NN are_VBP located_VBN in_IN a_DT region_NN that_WDT includes_VBZ the_DT 5'-noncoding_JJ region_NN along_IN with_IN the_DT 5_CD '_POS half_NN of_IN the_DT gag_NN gene_NN ._SENT These_DT sequences_NNS are_VBP referred_VBN to_TO as_IN the_DT "_`` packaging_NN "_'' or_CC "_`` encapsidation_NN "_'' signal_NN ._SENT The_DT packaging_NN signal_NN can_MD enhance_VB the_DT packaging_NN of_IN RNAs_NP containing_VBG the_DT signal_NN over_IN those_DT not_RB containing_VBG the_DT packaging_NN signal_NN ._SENT However_RB ,_, in_IN the_DT absence_NN of_IN RNAs_NP containing_VBG a_DT packaging_NN signal_NN ,_, cellular_JJ RNAs_NP can_MD be_VB packaged_VBN into_IN particles_NNS ,_, which_WDT supports_VBZ the_DT conclusion_NN that_IN RNA_NP is_VBZ a_DT structural_JJ element_NN in_IN retrovirus_NN particles_NNS ._SENT The_DT Gag_NP polyprotein_NN precursor_NN alone_RB is_VBZ sufficient_JJ for_IN the_DT formation_NN of_IN particles_NNS ,_, and_CC the_DT presence_NN of_IN RNA_NP aids_NNS in_IN efficient_JJ particle_NN production_NN ._SENT Since_IN activation_NN of_IN the_DT viral_JJ protease_NN does_VBZ not_RB typically_RB occur_VB until_IN after_IN virus_NN particle_NN release_NN ,_, the_DT genome_NN recognition_NN event_NN involves_VBZ full-length_JJ viral_JJ RNA_NP and_CC unprocessed_JJ Gag_NP polyprotein_NN ._SENT Gag_NN includes_VBZ three_CD main_JJ domains_NNS (_( matrix_NN [_SYM MA_NP ]_SYM ,_, capsid_NN [_SYM CA_NP ]_SYM ,_, and_CC NC_NP )_) ._SENT Attempts_NNS to_TO address_VB the_DT RNA_NP packaging_NN process_NN have_VBP focused_VBN on_IN identifying_VBG RNA-binding_NP domains_NNS within_IN unprocessed_JJ Gag_NP (_( and_CC the_DT processed_JJ Gag_NP products_NNS )_) and_CC demonstrating_VBG the_DT specificity_NN of_IN binding_VBG of_IN viral_JJ RNA_NP to_TO Gag_NP either_CC in_IN cell-free_JJ reactions_NNS or_CC in_IN the_DT uptake_NN of_IN viral_JJ RNA_NP into_IN virus_NN particles_NNS ._SENT The_DT NC_NP proteins_NNS of_IN all_DT retroviruses_NNS share_VBP the_DT characteristics_NNS of_IN a_DT high_JJ percentage_NN of_IN basic_JJ residues_NNS and_CC zinc_NN binding_VBG domains_NNS involved_VBN in_IN RNA_NP packaging_NN and_CC in_IN many_JJ instances_NNS alter_VBP the_DT specificity_NN of_IN RNA_NP binding_NN ._SENT It_PP is_VBZ not_RB clear_JJ whether_IN NC_NP actually_RB confers_VBZ all_DT of_IN the_DT selective_JJ recognition_NN of_IN the_DT viral_JJ genomic_JJ RNA_NP ._SENT The_DT p2_JJ spacer_NN peptide_NN between_IN CA_NP and_CC NC_NP of_IN human_JJ immunodeficiency_NN virus_NN type_NN 1_CD (_( HIV-1_NP )_) PrGag_NP has_VBZ been_VBN suggested_VBN to_TO play_VB a_DT role_NN in_IN selective_JJ RNA_NP packaging_NN ._SENT However_RB ,_, previous_JJ studies_NNS with_IN HIV-1_NP have_VBP indicated_VBN that_IN MA_NP does_VBZ not_RB play_VB a_DT role_NN in_IN RNA_NP packaging_NN ._SENT Bovine_JJ leukemia_NN virus_NN (_( BLV_NP )_) ,_, as_RB well_RB as_IN other_JJ deltaretroviruses_NNS ,_, replicates_VBZ to_TO low_JJ titers_NNS in_IN animals_NNS and_CC is_VBZ poorly_RB infectious_JJ in_IN cell_NN culture_NN ._SENT Cocultivation_NP is_VBZ typically_RB used_VBN to_TO infect_VB permissive_JJ host_NN cells_NNS ._SENT Because_IN of_IN these_DT difficulties_NNS ,_, information_NN regarding_VBG the_DT molecular_JJ details_NNS of_IN the_DT virus_NN life_NN cycles_NNS ,_, including_VBG virus_NN assembly_NN ,_, is_VBZ limited_VBN ._SENT To_TO more_RBR easily_RB study_VB the_DT RNA_NP packaging_NN step_NN in_IN the_DT virus_NN assembly_NN pathway_NN of_IN BLV_NP ,_, we_PP have_VBP used_VBN a_DT virus-like_JJ particle_NN (_( VLP_NP )_) model_NN system_NN to_TO identify_VB the_DT protein_NN determinants_NNS of_IN BLV_NP RNA_NP packaging_NN ._SENT As_IN expected_VBN ,_, many_JJ of_IN the_DT basic_JJ amino_NN acid_NN residues_NNS and_CC all_DT zinc_NN finger_NN residues_NNS mutated_VBN in_IN the_DT NC_NP domain_NN of_IN PrGag_NP led_VBD to_TO significant_JJ reductions_NNS in_IN RNA_NP packaging_NN ._SENT Interestingly_RB ,_, many_JJ of_IN the_DT basic_JJ residues_NNS in_IN MA_NP were_VBD also_RB found_VBN to_TO significantly_RB influence_VB RNA_NP packaging_NN ._SENT Together_RB ,_, these_DT observations_NNS provide_VBP the_DT first_JJ evidence_NN that_IN both_CC the_DT MA_NP and_CC NC_NP domains_NNS of_IN BLV_NP PrGag_NP are_VBP involved_VBN in_IN viral_JJ RNA_NP packaging_NN ._SENT VLP_NN vector_NN and_CC mutagenesis_NN ._SENT |_SYM The_DT vector_NN used_VBN to_TO produce_VB VLPs_NP ,_, pGag-HA_NP ,_, has_VBZ a_DT hemagglutinin_NN (_( HA_NP )_) epitope_NN tag_NN fused_VBD to_TO the_DT C_NP terminus_NN of_IN the_DT BLV_NP PrGag_NP ._SENT The_DT construction_NN of_IN this_DT vector_NN and_CC the_DT ability_NN of_IN the_DT vector_NN to_TO produce_VB VLPs_NP have_VB been_VBN described_VBN previously_RB ._SENT This_DT vector_NN transcribes_VBZ a_DT single_JJ RNA_NP transcript_NN and_CC no_DT spliced_VBN RNA_NP ._SENT The_DT RNA_NP is_VBZ translated_VBN to_TO express_VB PrGag_NP in_IN the_DT absence_NN of_IN the_DT viral_JJ protease_NN ._SENT Therefore_RB ,_, the_DT VLPs_NNS do_VBP not_RB have_VB mature_JJ cores_NNS ._SENT The_DT primary_JJ BLV_NP RNA_NP packaging_NN signal_NN ,_, consisting_VBG of_IN two_CD stable_JJ RNA_NP stem-loop_NN structures_NNS (_( i.e._FW ,_, SL1_NP and_CC SL2_NP )_) ,_, are_VBP located_VBN just_RB downstream_JJ of_IN the_DT gag_NN start_NN codon_NN (_( -_: )_) ._SENT Due_JJ to_TO the_DT presence_NN of_IN the_DT packaging_NN signal_NN ,_, this_DT RNA_NP transcript_NN can_MD be_VB packaged_VBN into_IN VLPs_NP through_IN the_DT interaction_NN with_IN PrGag_NP ._SENT In_IN this_DT system_NN ,_, the_DT VLP_NP expression_NN vector_NN transcribes_VBZ only_RB one_CD RNA_NP species_NNS due_JJ to_TO the_DT absence_NN of_IN the_DT BLV_NP splice_NN donor_NN and_CC splice_NN acceptor_NN sites_NNS ._SENT Site-directed_JJ mutations_NNS were_VBD introduced_VBN into_IN pGag-HA_NN by_IN using_VBG the_DT QuickChange_NP XL_NP kit_NN (_( Stratagene_NP ,_, La_NP Jolla_NP ,_, Calif._NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ._SENT All_DT derivatives_NNS made_VBN of_IN pGag-HA_NN were_VBD sequenced_JJ to_TO verify_VB the_DT correct_JJ introduction_NN of_IN the_DT desired_VBN mutation_NN and_CC the_DT absence_NN of_IN undesired_JJ mutations_NNS ._SENT Cells_NNS and_CC transfections_NNS ._SENT |_SYM To_TO express_VB BLV_NP PrGag_NP in_IN mammalian_JJ cells_NNS ,_, COS-1_JJ cells_NNS were_VBD transfected_VBN with_IN pGag-HA_NN or_CC a_DT derivative_JJ and_CC placed_VBN under_IN G418_NP selection_NN to_TO obtain_VB stable_JJ cells_NNS expressing_VBG PrGag_NP ._SENT Cells_NNS were_VBD grown_VBN in_IN 100-_CD ,_, 60-_CD ,_, or_CC 35-mm-diameter_JJ dishes_NNS in_IN Dulbecco_NP 's_POS modified_JJ Eagle_NP 's_POS medium_NN (_( GIBCO_NP BRL_NP ,_, Gaithersburg_NP ,_, Md._NP )_) supplemented_VBD with_IN 10_CD %_NN Fetal_NP Clone_NP III_NP serum_NN (_( HyClone_NP ,_, Logan_NP ,_, Utah_NP )_) ._SENT Superfect_NP (_( Qiagen_NP ,_, Valencia_NP ,_, Calif._NP )_) was_VBD used_VBN for_IN transfection_NN of_IN cells_NNS ._SENT Two_CD days_NNS posttransfection_NN ,_, cells_NNS were_VBD placed_VBN under_IN G418_NP selection_NN until_IN resistant_JJ colonies_NNS formed_VBN (_( similar3_NN weeks_NNS )_) ._SENT Approximately_RB 100_CD G418-resistant_JJ colonies_NNS were_VBD pooled_VBN and_CC used_VBN for_IN VLP_NP analysis_NN ._SENT Quantitation_NP of_IN VLP_NP production_NN ._SENT |_SYM Supernatant_NN from_IN pooled_JJ stable_JJ cell_NN clones_NNS producing_VBG VLPs_NP was_VBD harvested_VBN and_CC clarified_VBN by_IN low-speed_NN centrifugation_NN (_( 5_CD min_NN at_IN 700_CD x_NN g_NN )_) and_CC then_RB subjected_VBN to_TO ultracentrifugation_NN for_IN 1_CD h_NN at_IN 40,000_CD x_NN g_NN at_IN 4C_JJ ._SENT Pelleted_VBN VLPs_NP were_VBD then_RB resuspended_VBN in_IN radioimmunoprecipitation_NN assay_NN (_( RIPA_NP )_) buffer_NN (_( 1_CD %_NN IGEPAL_NP CA-630_NP ,_, 50_CD mM_NP Tris-HCl_NP [_SYM pH_NN 7.5_CD ]_SYM ,_, 150_CD mM_NP NaCl_NP ,_, 0.5_CD %_NN deoxycholate_NN [_SYM DOC_NP ]_SYM ,_, 5_CD mM_NP EDTA_NP ,_, 0.1_CD %_NN sodium_NN dodecyl_JJ sulfate_NN [_SYM SDS_NP ]_SYM )_) ._SENT Lysates_NNS prepared_VBN from_IN VLP-producing_JJ cells_NNS and_CC VLP_NP samples_NNS were_VBD subjected_VBN to_TO sodium_NN dodecyl_NN sulfate-polyacrylamide_NN gel_NN electrophoresis_NN (_( SDS-PAGE_NP )_) and_CC transferred_VBN to_TO nitrocellulose_NN ,_, and_CC BLV_NP Gag_NP was_VBD detected_VBN with_IN a_DT primary_JJ antibody_NN directed_VBN against_IN the_DT HA_NP epitope_NN tag_NN (_( Covance_NP ,_, Princeton_NP ,_, N.J._NP )_) and_CC an_DT antimouse_NN immunoglobulin_NN (_( Ig_NP )_) horseradish_NN peroxidase-linked_JJ whole_JJ antibody_NN (_( from_IN sheep_NN )_) as_IN a_DT secondary_JJ antibody_NN (_( Amersham_NP ,_, Arlington_NP Heights_NP ,_, Ill._NP )_) ._SENT Quantitation_NN of_IN band_NN intensities_NNS was_VBD done_VBN with_IN the_DT Quantity_NP One_CD software_NN package_NN with_IN the_DT Chemi_NP Doc_NP 2000_CD Documentation_NP System_NP (_( Bio-Rad_NP ,_, Richmond_NP ,_, Calif._NP )_) ._SENT Quantitation_NN of_IN viral_JJ RNA_NP in_IN cells_NNS and_CC VLPs_NNS and_CC determination_NN of_IN RNA_NP packaging_NN efficiencies_NNS ._SENT |_SYM Total_NP RNA_NP was_VBD extracted_VBN from_IN transfected_JJ cells_NNS by_IN using_VBG a_DT cellular_JJ RNA_NP extraction_NN kit_NN (_( Qiagen_NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ._SENT Viral_JJ RNA_NP was_VBD extracted_VBN with_IN a_DT QIAamp_NN viral_JJ RNA_NP kit_NN (_( Qiagen_NP )_) according_VBG to_TO the_DT manufacturers_NNS '_POS instructions_NNS ._SENT To_TO control_VB for_IN DNA_NN contamination_NN ,_, the_DT RNAs_NP isolated_VBD were_VBD treated_VBN with_IN DNase_NP I_NP (_( Invitrogen_NP )_) and_CC used_VBN in_IN reverse_JJ transcription-PCR_NN (_( RT-PCR_NP )_) without_IN the_DT addition_NN of_IN reverse_JJ transcriptase_NN to_TO confirm_VB the_DT absence_NN of_IN DNA_NP ._SENT Detection_NN of_IN the_DT RNA_NP transcript_NN that_WDT expresses_VBZ PrGag_NN in_IN cells_NNS and_CC its_PP$ incorporation_NN into_IN VLPs_NP due_JJ to_TO the_DT RNA_NP packaging_NN signal_NN was_VBD done_VBN by_IN quantitative_JJ real-time_JJ RT-PCR_NP analysis_NN ._SENT Quantitative_JJ real-time_JJ RT-PCR_NP was_VBD carried_VBN out_RP with_IN the_DT Qiagen_NP RT-PCR_NP Master_NP SYBR_NP Green_NP kit_NN in_IN a_DT 20-mul_JJ reaction_NN volume_NN ._SENT RNA_NP templates_NNS were_VBD reverse_RB transcribed_VBN at_IN 50C_NN for_IN 25_CD min_NN followed_VBN by_IN a_DT denaturing_VBG step_NN at_IN 95C_NN for_IN 15_CD min_NN ._SENT PCR_NP was_VBD then_RB performed_VBN with_IN the_DT primers_NNS +BLV979_NN (_( 5'-AACCGCCATCGTGCTTGGGCA-3_NP '_POS )_) and_CC -BLV1183_NP (_( 5'-CGCTTCAGCGGCGGCTATTGC-3_NP '_POS )_) ._SENT These_DT primers_NNS amplify_VBP an_DT approximately_RB 200-bp-long_JJ fragment_NN within_IN the_DT gag_NN gene_NN ._SENT The_DT PCR_NP protocol_NN consisted_VBD of_IN 50_CD cycles_NNS of_IN denaturation_NN (_( 95C_NN for_IN 15_CD s_NNS )_) ,_, annealing_VBG (_( 60C_JJ for_IN 20_CD s_NNS )_) ,_, and_CC extension_NN (_( 72C_JJ for10_NN s_NNS )_) ._SENT For_IN each_DT step_NN ,_, the_DT temperature_NN transition_NN rate_NN was_VBD 20C/s_JJ ._SENT The_DT PCR_NP was_VBD monitored_VBN with_IN a_DT Light_NP Cycler_NP (_( Roche_NP Diagnostics_NP )_) after_IN each_DT elongation_NN step_NN by_IN SYBR_NP Green_NP I_PP dye_VBP binding_VBG to_TO amplified_VBN products_NNS ._SENT Quantitation_NN was_VBD carried_VBN out_RP with_IN an_DT external_JJ standard_JJ curve_NN ._SENT Standard_NP RNA_NP was_VBD synthesized_VBN by_IN in_IN vitro_NN transcription_NN of_IN a_DT linearized_JJ plasmid_NN containing_VBG a_DT BLV_NP proviral_JJ DNA_NN representing_VBG the_DT 5_CD '_POS end_NN of_IN the_DT gag_NN gene_NN ._SENT All_RB in_IN vitro_NN transcripts_NNS were_VBD DNase_NP I_PP treated_VBD and_CC tested_VBD for_IN DNA_NN contamination_NN ._SENT Standard_JJ curves_NNS were_VBD constructed_VBN from_IN 10-fold_JJ serial_JJ dilutions_NNS of_IN synthetic_JJ RNA_NP transcripts_NNS ._SENT After_IN real-time_JJ RT-PCR_NP was_VBD completed_VBN ,_, logarithmic_JJ values_NNS of_IN fluorescence_NN for_IN each_DT dilution_NN were_VBD plotted_VBN against_IN cycle_NN number_NN ._SENT A_DT baseline_NN was_VBD set_VBN just_RB above_IN the_DT fluorescence_NN background_NN ,_, and_CC a_DT crossing_VBG point_NN was_VBD determined_VBN with_IN amplification_NN curves_NNS obtained_VBN during_IN the_DT initial_JJ exponential_JJ phase_NN of_IN amplification_NN ._SENT The_DT specificity_NN of_IN the_DT amplified_VBN product_NN was_VBD then_RB determined_VBN by_IN melting_VBG curve_NN analysis_NN ._SENT Melting_VBG curve_NN acquisitions_NNS were_VBD done_VBN immediately_RB after_IN PCR_NP was_VBD completed_VBN ,_, by_IN heating_NN at_IN 95C_NN for_IN 0_CD s_NNS ,_, cooling_VBG to_TO 75C_NP for_IN 15_CD s_NNS ,_, and_CC heating_VBG slowly_RB at_IN 20C/s_JJ until_IN 95C_NN with_IN continuous_JJ fluorescence_NN recording_NN ._SENT RNA_NP packaging_NN efficiencies_NNS were_VBD determined_VBN by_IN the_DT ratio_NN of_IN viral_JJ RNA_NP detected_VBD from_IN VLPs_NP to_TO viral_JJ RNA_NP detected_VBD from_IN total_JJ RNA_NP recovered_VBD from_IN VLP-producing_NN cells_NNS divided_VBN by_IN the_DT ratio_NN of_IN Gag_NP protein_NN detected_VBD from_IN VLPs_NP to_TO Gag_NP protein_NN detected_VBD from_IN VLP-producing_NN cells_NNS ._SENT RNA_NP packaging_NN efficiencies_NNS of_IN mutants_NNS were_VBD then_RB compared_VBN relative_JJ to_TO that_DT of_IN the_DT parental_JJ pGag-HA_NN vector_NN ._SENT Confocal_JJ microscopy_NN ._SENT |_SYM Transfected_JJ cells_NNS were_VBD grown_VBN on_IN coverslips_NNS ,_, fixed_VBN with_IN 4_CD %_NN paraformaldehyde_NN ,_, and_CC permeabilized_VBN with_IN Triton_NP X-100_NP ,_, both_CC diluted_VBN in_IN phosphate-buffered_JJ saline_NN ._SENT The_DT cells_NNS were_VBD then_RB incubated_VBN with_IN anti-HA_NP antibody_NN followed_VBD by_IN incubation_NN with_IN Alexa_NP Fluor_NP 488-conjugated_JJ goat_NN anti-mouse_NN IgG_NP (_( Molecular_NP Probes_NP )_) ._SENT Images_NNS were_VBD collected_VBN with_IN a_DT Bio-Rad_NP MRC_NP 600_CD confocal_JJ microscope_NN ._SENT Effects_NNS of_IN mutations_NNS in_IN the_DT NC_NP domain_NN of_IN PrGag_NP on_IN RNA_NP packaging_NN ._SENT |_SYM In_IN order_NN to_TO determine_VB the_DT influence_NN of_IN NC_NP on_IN RNA_NP packaging_NN ,_, a_DT series_NN of_IN NC_NP mutants_NNS were_VBD made_VBN in_IN pGag-HA_NN and_CC tested_VBN for_IN their_PP$ ability_NN to_TO influence_VB RNA_NP packaging_NN ._SENT Alanine_NN residues_NNS were_VBD introduced_VBN in_IN place_NN of_IN basic_JJ amino_NN acid_NN residues_NNS and_CC in_IN place_NN of_IN the_DT conserved_VBN residues_NNS in_IN each_DT of_IN the_DT two_CD zinc_NN finger_NN binding_VBG domains_NNS ._SENT The_DT panel_NN of_IN NC_NP mutants_NNS was_VBD analyzed_VBN in_IN parallel_NN with_IN the_DT parental_JJ vector_NN ._SENT Figure_NN shows_VBZ the_DT RNA_NP packaging_NN efficiencies_NNS of_IN the_DT mutants_NNS ._SENT There_EX were_VBD three_CD groups_NNS of_IN mutant_JJ phenotypes_NNS ._SENT The_DT first_JJ group_NN of_IN mutants_NNS had_VBD no_DT RNA_NP packaging_NN defects_NNS compared_VBN to_TO the_DT parental_JJ vector_NN ._SENT These_DT mutants_NNS included_VBD K17A_NP and_CC R18A_NP ._SENT A_DT second_JJ group_NN of_IN mutants_NNS had_VBD mild_JJ RNA_NP packaging_NN defects_NNS (_( 40_CD to_TO 70_CD %_NN reduction_NN in_IN VLP_NP production_NN )_) (_( i.e._FW ,_, R12A_NP ,_, K17A/R18A_NP ,_, K59A_NP ,_, K66A_NP ,_, and_CC K68A_NP )_) ._SENT The_DT third_JJ group_NN of_IN mutants_NNS had_VBD severe_JJ RNA_NP packaging_NN defects_NNS compared_VBN to_TO the_DT parental_JJ vector_NN (_( 85_CD to_TO 95_CD %_NN reduction_NN )_) (_( i.e._FW ,_, C24A_NP ,_, C27A_NP ,_, R35A_NP ,_, C49A_NP ,_, H57A_NP ,_, and_CC R60A_NP )_) ._SENT For_IN many_JJ of_IN the_DT mutants_NNS ,_, VLP_NP production_NN was_VBD reduced_VBN two-_NN to_TO threefold_RB that_IN of_IN the_DT parental_JJ vector_NN (_( i.e._FW ,_, R12A_NP ,_, K17A_NP ,_, R18A_NP ,_, K17A/R18A_NP ,_, R35A_NP ,_, and_CC C49A_NP )_) ._SENT This_DT reduction_NN is_VBZ within_IN the_DT linear_JJ detection_NN range_NN for_IN the_DT immunoblot_NN assay_NN used_VBN (_( described_VBN below_IN )_) ._SENT As_IN predicted_VBN ,_, many_JJ of_IN the_DT basic_JJ amino_NN acid_NN residues_NNS that_WDT were_VBD mutated_VBN led_VBN to_TO significant_JJ reductions_NNS in_IN RNA_NP packaging_NN efficiencies_NNS ._SENT The_DT mutated_VBN basic_JJ residues_NNS that_WDT resulted_VBD in_IN the_DT greatest_JJS reductions_NNS were_VBD R35A_NP and_CC R60A_NP ._SENT Interestingly_RB ,_, each_DT of_IN these_DT residues_NNS lies_VBZ between_IN the_DT conserved_VBN histidine_NN and_CC cysteine_NN residues_NNS in_IN the_DT first_JJ (_( i.e._FW ,_, R35A_NP )_) and_CC second_JJ (_( i.e._FW ,_, R60A_NP )_) zinc_NN finger_NN domains_NNS ._SENT Effects_NNS of_IN mutations_NNS in_IN the_DT MA_JJ domain_NN of_IN PrGag_NP on_IN RNA_NP packaging_NN ._SENT |_SYM Previous_JJ studies_NNS with_IN other_JJ retroviruses_NNS have_VBP provided_VBN little_JJ support_NN for_IN a_DT role_NN of_IN the_DT MA_JJ domain_NN in_IN retroviral_JJ RNA_NP packaging_NN ._SENT To_TO test_VB whether_IN basic_JJ residues_NNS in_IN the_DT BLV_NP MA_NP domain_NN influence_NN RNA_NP packaging_NN ,_, a_DT panel_NN of_IN mutants_NNS that_WDT changed_VBD basic_JJ residues_NNS in_IN MA_NN to_TO alanine_NN was_VBD created_VBN ._SENT The_DT RNA_NP packaging_NN efficiencies_NNS of_IN the_DT mutants_NNS were_VBD then_RB analyzed_VBN in_IN parallel_NN with_IN the_DT parental_JJ vector_NN ._SENT Figure_NN shows_VBZ a_DT representative_JJ protein_NN analysis_NN of_IN Gag_NP from_IN cells_NNS and_CC VLPs_NNS ._SENT The_DT K52A_NP and_CC K53A_NP MA_NP mutants_NNS led_VBD to_TO the_DT lowest_JJS levels_NNS of_IN VLPs_NP (_( 8_CD and_CC 17_CD %_NN ,_, respectively_RB )_) ._SENT These_DT reductions_NNS are_VBP within_IN 13-fold_NN of_IN the_DT level_NN of_IN the_DT parental_JJ vector_NN and_CC are_VBP within_IN the_DT linear_JJ range_NN of_IN detection_NN for_IN the_DT assay_NN ,_, which_WDT was_VBD at_IN least_JJS 16-fold_NN ._SENT Figure_NN shows_VBZ the_DT resulting_JJ RNA_NP packaging_NN efficiencies_NNS for_IN the_DT panel_NN of_IN MA_JJ mutants_NNS tested_VBD ._SENT As_RB with_IN the_DT NC_NP mutants_NNS ,_, there_EX were_VBD three_CD general_JJ groups_NNS of_IN mutant_JJ phenotypes_NNS ._SENT Several_JJ basic_JJ residues_NNS that_WDT are_VBP not_RB conserved_VBN among_IN BLV_NP ,_, human_JJ T-cell_NN leukemia_NN virus_NN type_NN 1_CD (_( HTLV-1_NP )_) ,_, and_CC HTLV-2_NP led_VBD to_TO no_DT or_CC small_JJ changes_NNS in_IN RNA_NP packaging_NN efficiencies_NNS (_( i.e._FW ,_, R31A_NP ,_, H48A_NP ,_, K53A_NP ,_, R69A_NP ,_, and_CC R72A_NP )_) ._SENT A_DT second_JJ group_NN led_VBN to_TO modest_JJ reductions_NNS in_IN RNA_NP packaging_NN efficiencies_NNS (_( i.e._FW ,_, R27A_NP and_CC K52A_NP )_) ._SENT Finally_RB ,_, a_DT third_JJ group_NN had_VBD significant_JJ reductions_NNS in_IN RNA_NP packaging_NN (_( 66_CD to_TO 92_CD %_NN )_) compared_VBN to_TO that_DT of_IN the_DT parental_JJ vector_NN (_( K41A_NP and_CC H45A_NP )_) ._SENT The_DT H45A_NP MA_NN mutant_NN had_VBD a_DT reduction_NN in_IN RNA_NP packaging_NN efficiency_NN (_( 92_CD %_NN )_) that_WDT was_VBD as_RB great_JJ as_IN any_DT of_IN those_DT in_IN the_DT individual_JJ NC_NP mutants_NNS ,_, indicating_VBG that_IN BLV_NP MA_NP plays_VBZ an_DT important_JJ role_NN in_IN RNA_NP packaging_NN ._SENT The_DT K49_NP residue_NN was_VBD not_RB analyzed_VBN in_IN this_DT study_NN ._SENT In_IN other_JJ retroviruses_NNS ,_, such_JJ as_IN HIV-1_NP ,_, basic_JJ amino_NN acid_NN residues_NNS in_IN MA_NP can_MD influence_VB PrGag_NP membrane_NN targeting_VBG and_CC are_VBP proposed_VBN to_TO form_VB a_DT positively_RB charged_VBN patch_NN that_WDT promotes_VBZ membrane_NN binding_NN ._SENT To_TO determine_VB whether_IN MA_JJ mutants_NNS that_WDT significantly_RB reduced_VBD RNA_NP packaging_NN also_RB influenced_VBN PrGag_NP membrane_NN localization_NN ,_, the_DT cellular_JJ distribution_NN of_IN Gag_NP was_VBD analyzed_VBN by_IN confocal_JJ microscopy_NN ._SENT Figure_NN shows_VBZ the_DT effects_NNS of_IN several_JJ basic_JJ amino_NN acid_NN mutants_NNS on_IN Gag_NP distribution_NN in_IN cells_NNS ._SENT These_DT mutants_NNS (_( i.e._FW ,_, R27A_NP ,_, K41A_NP ,_, H45A_NP ,_, K52A_NP ,_, and_CC K53A_NP )_) had_VBD a_DT cellular_JJ distribution_NN of_IN Gag_NP that_WDT was_VBD comparable_JJ to_TO that_WDT observed_VBD with_IN the_DT wild_JJ type_NN ._SENT Specifically_RB ,_, Gag_NP expression_NN yielded_VBD a_DT stippled_VBN appearance_NN along_IN the_DT plasma_NN membrane_NN for_IN the_DT parental_JJ Gag_NP and_CC for_IN these_DT mutants_NNS ._SENT Importance_NN of_IN charged_VBN amino_NN acid_NN residues_NNS in_IN MA_NN on_IN RNA_NP packaging_NN ._SENT |_SYM The_DT MA_JJ residues_NNS R27_JJ and_CC H45_NP ,_, when_WRB mutated_VBN ,_, revealed_VBD significant_JJ reductions_NNS in_IN RNA_NP packaging_NN efficiencies_NNS ._SENT To_TO further_RBR analyze_VB the_DT importance_NN of_IN these_DT positively_RB charged_VBN amino_NN acid_NN residues_NNS on_IN RNA_NP packaging_NN ,_, mutations_NNS were_VBD made_VBN at_IN either_DT R27_NP or_CC H45_NP to_TO create_VB either_RB a_DT conservative_JJ (_( i.e._FW ,_, R27H_NP or_CC H45R_NP )_) or_CC nonconservative_JJ (_( i.e._FW ,_, R27G_NP or_CC H45G_NP )_) change_NN at_IN these_DT residues_NNS ._SENT Figure_NN shows_VBZ the_DT effects_NNS of_IN these_DT amino_NN acid_NN substitutions_NNS on_IN RNA_NP packaging_NN ._SENT R27G_NP had_VBD a_DT phenotype_NN comparable_JJ to_TO that_DT of_IN R27A_NP ,_, while_IN R27H_NP had_VBD a_DT phenotype_NN that_WDT was_VBD comparable_JJ to_TO that_DT of_IN the_DT parental_JJ vector_NN ._SENT Furthermore_RB ,_, H45G_NP had_VBD an_DT RNA_NP packaging_NN defect_NN similar_JJ to_TO that_DT of_IN H45A_NP ,_, while_IN H45R_NP had_VBD a_DT phenotype_NN equivalent_NN to_TO that_DT of_IN the_DT parental_JJ vector_NN ._SENT These_DT data_NNS indicate_VBP that_IN there_EX is_VBZ a_DT correlation_NN between_IN the_DT absence_NN of_IN a_DT positively_RB charged_VBN amino_NN acid_NN at_IN positions_NNS 27_CD or_CC 45_CD and_CC a_DT defect_NN in_IN RNA_NP packaging_NN ._SENT The_DT cellular_JJ distribution_NN of_IN Gag_NP was_VBD not_RB influenced_VBN by_IN these_DT mutations_NNS ,_, indicating_VBG there_EX was_VBD no_DT correlation_NN between_IN the_DT RNA_NP packaging_NN defects_NNS and_CC Gag_NP membrane_NN localization_NN ._SENT Combined_JJ effect_NN of_IN MA_NP and_CC NC_NP mutations_NNS on_IN RNA_NP packaging_NN ._SENT |_SYM To_TO test_VB for_IN the_DT potential_JJ interplay_NN between_IN MA_NP and_CC NC_NP on_IN RNA_NP packaging_NN ,_, a_DT mutant_JJ construct_NN was_VBD created_VBN in_IN which_WDT both_DT MA_NP and_CC NC_NP mutations_NNS were_VBD introduced_VBN into_IN the_DT same_JJ vector_NN and_CC then_RB assayed_VBN for_IN the_DT ability_NN to_TO package_VB RNA_NP ._SENT In_IN particular_JJ ,_, the_DT MA/NC_NP double_JJ mutant_JJ MA_NN H45A/NC_NP C24A_NP was_VBD tested_VBN ._SENT The_DT combined_JJ mutant_NN had_VBD a_DT 10-fold_NN reduction_NN in_IN VLP_NP production_NN and_CC a_DT severe_JJ defect_NN in_IN RNA_NP packaging_NN (_( 98_CD %_NN reduction_NN compared_VBN to_TO that_DT of_IN the_DT parental_JJ strain_NN )_) that_WDT was_VBD significantly_RB lower_JJR than_IN the_DT RNA_NP packaging_NN efficiency_NN of_IN either_DT mutant_NN alone_RB ._SENT This_DT indicates_VBZ that_IN the_DT combination_NN of_IN mutations_NNS together_RB further_RBR reduced_VBN the_DT efficiency_NN of_IN RNA_NP packaging_NN ._SENT Lack_NN of_IN transient_JJ nuclear_JJ localization_NN of_IN Gag_NP ._SENT |_SYM A_DT recent_JJ study_NN with_IN Rous_NP sarcoma_NN virus_NN (_( RSV_NP )_) revealed_VBD that_IN RSV_NP Gag_NP protein_NN enters_VBZ the_DT nucleus_NN by_IN a_DT nuclear-targeting_JJ sequence_NN in_IN the_DT MA_JJ domain_NN and_CC is_VBZ subsequently_RB transported_VBN to_TO the_DT cytoplasm_NN by_IN using_VBG a_DT CRM1-mediated_JJ nuclear_JJ export_NN pathway_NN ._SENT Transient_JJ expression_NN of_IN a_DT dominant-negative_JJ CRM1_NP or_CC by_IN treating_VBG cells_NNS with_IN leptomycin_NN B_NP (_( LMB_NP ;_: a_DT drug_NN that_WDT attaches_VBZ to_TO the_DT central_JJ domain_NN of_IN CRM1_NP to_TO disrupt_VB its_PP$ interaction_NN with_IN nuclear_JJ export_NN signals_NNS )_) resulted_VBN in_IN the_DT redistribution_NN of_IN Gag_NP from_IN the_DT cytoplasm_NN to_TO the_DT nucleus_NN ._SENT The_DT MA_JJ mutant_NN ,_, Myr1E_NP ,_, was_VBD insensitive_JJ to_TO the_DT effects_NNS of_IN LMB_NP treatment_NN ,_, apparently_RB because_IN it_PP bypassed_VBD the_DT nuclear_JJ compartment_NN during_IN virus_NN assembly_NN ._SENT Myr1E_NP has_VBZ a_DT defect_NN in_IN RNA_NP packaging_NN ,_, which_WDT implies_VBZ that_DT RSV_NP nuclear_JJ localization_NN of_IN Gag_NP might_MD be_VB involved_VBN in_IN viral_JJ RNA-Gag_NP interactions_NNS ._SENT Since_IN we_PP discovered_VBD BLV_NP MA_NP mutants_NNS with_IN RNA_NP packaging_NN defects_NNS like_IN Myr1E_NN ,_, we_PP hypothesized_VBD that_IN the_DT viral_JJ RNA-Gag_NP interactions_NNS involved_VBN in_IN BLV_NP RNA_NP packaging_NN might_MD occur_VB in_IN the_DT nucleus_NN after_IN transient_JJ nuclear_JJ localization_NN of_IN Gag_NP ._SENT To_TO test_VB whether_IN BLV_NP Gag_NP is_VBZ localized_VBN in_IN the_DT nucleus_NN ,_, 293T_JJ cells_NNS transiently_RB transfected_VBN with_IN the_DT BLV_NP VLP_NP construct_NN PR+_NP were_VBD treated_VBN with_IN either_DT LMB_NP or_CC transiently_RB cotransfected_JJ with_IN a_DT dominant-negative_JJ CRM1_NP (_( DeltaCAN_NP )_) ._SENT In_IN addition_NN ,_, fetal_JJ lamb_NN kidney_NN cells_NNS chronically_RB infected_VBN with_IN BLV_NP (_( FLK-BLV_NP )_) were_VBD either_RB treated_VBN with_IN LMB_NP or_CC transiently_RB transfected_JJ with_IN DeltaCAN_NP ._SENT When_WRB 293T_JJ cells_NNS were_VBD either_RB cotransfected_JJ with_IN an_DT RSV_NP Gag-green_NP fluorescent_JJ protein_NN (_( GFP_NP )_) construct_NN and_CC DeltaCAN_NP or_CC transfected_VBN with_IN Gag-GFP_NP and_CC then_RB treated_VBN with_IN LMB_NP ,_, there_EX was_VBD a_DT distinct_JJ nuclear_JJ localization_NN of_IN Gag-GFP_NP ,_, comparable_JJ to_TO that_DT originally_RB reported_VBN by_IN Scheifele_NP et_FW al._FW ._SENT When_WRB 293T_JJ cells_NNS were_VBD either_RB cotransfected_JJ with_IN the_DT BLV_NP vector_NN and_CC DeltaCAN_NP or_CC treated_VBN with_IN LMB_NP after_IN transfection_NN with_IN the_DT BLV_NP vector_NN ,_, no_DT BLV_NP Gag_NP was_VBD observed_VBN in_IN the_DT nucleus_NN of_IN cells_NNS ._SENT Comparable_JJ results_NNS were_VBD obtained_VBN with_IN LMB_NP treatment_NN or_CC transfection_NN of_IN DeltaCAN_NP into_IN FLK-BLV_NP cells_NNS ._SENT One_CD interpretation_NN of_IN these_DT data_NN is_VBZ that_IN BLV_NP Gag_NP does_VBZ not_RB enter_VB the_DT nucleus_NN ,_, implying_VBG that_IN the_DT genome_NN recognition_NN event_NN occurs_VBZ in_IN the_DT cytoplasm_NN ._SENT However_RB ,_, it_PP is_VBZ possible_JJ that_IN BLV_NP Gag_NP does_VBZ enter_VB the_DT nucleus_NN and_CC is_VBZ exported_VBN by_IN a_DT CRM1-independent_JJ pathway_NN ._SENT This_DT is_VBZ the_DT first_JJ report_NN to_TO provide_VB direct_JJ genetic_JJ evidence_NN that_IN both_CC the_DT MA_NP and_CC NC_NP domains_NNS of_IN BLV_NP PrGag_NP are_VBP protein_NN determinants_NNS of_IN RNA_NP packaging_NN ._SENT The_DT unique_JJ observation_NN in_IN this_DT study_NN is_VBZ the_DT identification_NN of_IN several_JJ basic_JJ amino_NN acid_NN residues_NNS in_IN MA_NN that_IN when_WRB mutated_VBN ,_, led_VBN to_TO RNA_NP packaging_NN defects_NNS as_IN great_JJ as_RB ,_, if_IN not_RB greater_JJR than_IN ,_, those_DT observed_VBN for_IN single-amino-acid_JJ changes_NNS in_IN NC_NP ._SENT These_DT observations_NNS imply_VBP that_IN BLV_NP ,_, and_CC perhaps_RB other_JJ deltaretroviruses_NNS ,_, use_VBP distinct_JJ viral_JJ RNA-protein_NP interactions_NNS in_IN genome_NN recognition_NN and_CC RNA_NP packaging_NN ._SENT An_DT interesting_JJ observation_NN made_VBN with_IN the_DT MA_JJ mutants_NNS analyzed_VBN in_IN this_DT study_NN is_VBZ that_IN the_DT basic_JJ residues_NNS in_IN MA_NNS that_WDT influenced_VBD RNA_NP packaging_NN had_VBD no_DT effect_NN on_IN Gag_NP membrane_NN localization_NN ._SENT This_DT is_VBZ in_IN contrast_NN to_TO studies_NNS with_IN HIV-1_NP that_WDT indicate_VBP a_DT role_NN for_IN the_DT basic_JJ amino_NN residues_NNS of_IN MA_NN in_IN membrane_NN localization_NN (_( by_IN the_DT formation_NN of_IN a_DT charged_VBN patch_NN that_WDT is_VBZ thought_VBN to_TO promote_VB membrane_NN binding_NN )_) ._SENT However_RB ,_, our_PP$ data_NNS support_VBP those_DT from_IN a_DT previous_JJ study_NN of_IN the_DT basic_JJ residues_NNS in_IN the_DT HTLV-1_NP MA_NP ,_, which_WDT found_VBD that_IN HTLV-1_NP MA_NP basic_JJ residue_NN mutants_NNS led_VBN to_TO normal_JJ transport_NN of_IN Gag_NP to_TO the_DT membrane_NN as_RB well_RB as_IN cleavage_NN of_IN PrGag_NP ._SENT Many_JJ of_IN these_DT HTLV-1_NP mutants_NNS had_VBD reduced_VBN infectivity_NN ._SENT Our_PP$ study_NN found_VBD that_IN several_JJ of_IN the_DT BLV_NP MA_NP basic_JJ residue_NN mutants_NNS affected_VBN RNA_NP packaging_NN and_CC did_VBD not_RB influence_VB Gag_NP membrane_NN targeting_VBG (_( although_IN they_PP did_VBD lead_VB to_TO reductions_NNS in_IN virus_NN particle_NN production_NN )_) ,_, suggesting_VBG that_IN the_DT reduced_VBN infectivity_NN observed_VBN with_IN the_DT HTLV-1_JJ mutants_NNS may_MD be_VB (_( in_IN some_DT cases_NNS )_) related_VBN to_TO an_DT RNA_NP packaging_NN defect_NN ._SENT The_DT locations_NNS of_IN the_DT basic_JJ residues_NNS that_WDT led_VBD to_TO defects_NNS in_IN RNA_NP packaging_NN help_NN to_TO provide_VB some_DT mechanistic_JJ insights_NNS into_IN potential_JJ viral_JJ RNA-protein_NP interactions_NNS involved_VBN in_IN genome_NN recognition_NN ._SENT Among_IN the_DT NC_NP mutants_NNS ,_, the_DT residues_NNS that_WDT lie_VBP within_IN the_DT first_JJ and_CC second_JJ zinc_NN finger_NN domains_NNS ,_, including_VBG R35_NP and_CC R60_NP ,_, had_VBD a_DT significant_JJ impact_NN on_IN RNA_NP packaging_NN ._SENT Similar_JJ residues_NNS in_IN the_DT HIV-1_NP NC_NP zinc_NN finger_NN have_VBP been_VBN implicated_VBN in_IN interactions_NNS with_IN SL3_NP RNA_NP and_CC have_VBP been_VBN shown_VBN to_TO be_VB important_JJ for_IN RNA_NP packaging_NN by_IN mutagenesis_NN studies_NNS ._SENT The_DT basic_JJ residues_NNS in_IN the_DT BLV_NP MA_NN that_WDT caused_VBD the_DT greatest_JJS defects_NNS in_IN RNA_NP packaging_NN (_( i.e._FW ,_, K41_NP and_CC H45_NP )_) are_VBP located_VBN in_IN alpha-helix_NP B_NP ._SENT Presently_RB ,_, no_DT structural_JJ data_NNS are_VBP available_JJ regarding_VBG the_DT potential_JJ viral_JJ RNA-MA_NP protein_NN interactions_NNS ._SENT However_RB ,_, it_PP has_VBZ been_VBN previously_RB reported_VBN that_IN BLV_NP MA_NP specifically_RB interacts_VBZ with_IN the_DT viral_JJ RNA_NP in_IN a_DT region_NN that_WDT spans_VBZ the_DT locations_NNS of_IN SL1_NP and_CC SL2_NP ._SENT This_DT suggests_VBZ that_IN the_DT contacts_NNS made_VBN by_IN BLV_NP MA_NP with_IN the_DT viral_JJ RNA_NP may_MD also_RB involve_VB an_DT interaction_NN with_IN SL1_NP and/or_CC SL2_NP ._SENT Interestingly_RB ,_, the_DT HIV-1_NP MA_NN protein_NN has_VBZ been_VBN found_VBN to_TO bind_VB to_TO the_DT viral_JJ RNA_NP in_IN the_DT pol_NN gene_NN ,_, via_IN the_DT basic_JJ amino_NN acids_NNS in_IN MA_NN ,_, and_CC virus_NN mutants_NNS that_WDT disrupted_VBD this_DT RNA-protein_NP interaction_NN had_VBD delayed_VBN replication_NN kinetics_NNS ,_, although_IN no_DT role_NN in_IN RNA_NP packaging_NN was_VBD reported_VBN ._SENT The_DT BLV_NP MA_NN mutants_NNS in_IN this_DT study_NN that_WDT influenced_VBD RNA_NP packaging_NN do_VBP not_RB overlap_VB with_IN the_DT known_JJ RNA_NP sequence_NN of_IN gag_NN known_VBN to_TO be_VB involved_VBN in_IN RNA_NP packaging_NN ._SENT This_DT indicates_VBZ that_IN the_DT mutations_NNS introduced_VBN into_IN the_DT VLP_NP vector_NN influence_NN RNA_NP packaging_NN by_IN the_DT amino_NN acid_NN change_NN in_IN MA_NN and_CC not_RB the_DT nucleotide_NN changes_NNS in_IN the_DT RNA_NP ._SENT This_DT conclusion_NN is_VBZ supported_VBN by_IN the_DT data_NNS in_IN Fig._NN ,_, which_WDT show_VBP the_DT importance_NN of_IN charged_VBN amino_NN acid_NN residues_NNS (_( and_CC not_RB just_RB nucleotide_NN changes_NNS )_) in_IN RNA_NP packaging_NN ._SENT The_DT magnitude_NN of_IN the_DT defects_NNS in_IN RNA_NP packaging_NN described_VBD here_RB in_IN this_DT study_NN for_IN the_DT most_RBS extreme_JJ MA_NP and_CC NC_NP mutants_NNS (_( i.e._FW ,_, a_DT MA-NC_NP double_JJ mutant_NN )_) are_VBP in_IN the_DT range_NN of_IN those_DT observed_JJ previously_RB when_WRB SL1_NP or_CC SL2_NP was_VBD mutated_VBN ._SENT Taken_VBN together_RB ,_, these_DT observations_NNS suggest_VBP that_IN residues_NNS in_IN both_DT MA_NP and_CC NC_NP make_VBP direct_JJ contacts_NNS with_IN the_DT packaging_NN signal_NN or_CC perhaps_RB adjacent_JJ sequences_NNS that_WDT would_MD influence_VB genome_NN recognition_NN ._SENT The_DT interaction_NN of_IN NC_NP with_IN RNA_NP sequences_NNS outside_JJ of_IN those_DT RNA_NP secondary_JJ structures_NNS of_IN the_DT RNA_NP packaging_NN signal_NN has_VBZ been_VBN shown_VBN directly_RB or_CC implied_VBN with_IN murine_JJ leukemia_NN virus_NN and_CC spleen_NN necrosis_NN virus_NN and_CC is_VBZ believed_VBN to_TO play_VB an_DT important_JJ role_NN in_IN RNA_NP packaging_NN ._SENT The_DT data_NNS in_IN this_DT report_NN provide_VB evidence_NN for_IN a_DT role_NN of_IN both_CC the_DT MA_NP and_CC NC_NP domains_NNS of_IN Gag_NP in_IN BLV_NP RNA_NP packaging_NN ._SENT This_DT observation_NN implies_VBZ that_IN distinct_JJ viral_JJ RNA-protein_NP interactions_NNS occur_VBP in_IN BLV_NP genome_NN recognition_NN and_CC RNA_NP packaging_NN to_TO that_DT of_IN other_JJ retroviruses_NNS ._SENT Further_JJR studies_NNS will_MD determine_VB the_DT precise_JJ RNA-protein_NP interactions_NNS involved_VBN in_IN BLV_NP RNA_NP packaging_NN ,_, the_DT location_NN in_IN the_DT cell_NN at_IN which_WDT genome_NN recognition_NN occurs_VBZ ,_, and_CC whether_IN both_DT MA_NP and_CC NC_NP play_VBP a_DT role_NN in_IN RNA_NP packaging_NN of_IN other_JJ deltaretroviruses_NNS ._SENT Mutagenesis_NN of_IN basic_JJ residues_NNS and_CC the_DT zinc_NN fingers_NNS in_IN the_DT BLV_NP NC_NP domain_NN of_IN PrGag_NP results_NNS in_IN RNA_NP packaging_NN defects_NNS ._SENT Mutagenesis_NN of_IN basic_JJ residues_NNS and_CC the_DT zinc_NN fingers_NNS in_IN the_DT BLV_NP NC_NP domain_NN of_IN PrGag_NP results_NNS in_IN RNA_NP packaging_NN defects_NNS ._SENT (_( A_NP )_) The_DT BLV_NP NC_NP domain_NN of_IN PrGag_NP ._SENT Amino_NN acid_NN residues_NNS in_IN boldface_JJ indicate_VBP basic_JJ residues_NNS ,_, and_CC boldface_JJ residues_NNS that_WDT are_VBP underlined_VBN indicate_VBP basic_JJ and/or_CC charged_JJ residues_NNS conserved_VBN among_IN BLV_NP ,_, HTLV-1_NP ,_, and_CC HTLV-2_NP ._SENT The_DT locations_NNS of_IN the_DT two_CD zinc_NN finger_NN (_( Cys-His_NP box_NN )_) domains_NNS within_IN NC_NP are_VBP indicated_VBN ._SENT (_( B_NP )_) Relative_NP RNA_NP packaging_NN efficiencies_NNS of_IN BLV_NP NC_NP mutants_NNS ._SENT RNA_NP packaging_NN efficiencies_NNS were_VBD determined_VBN by_IN the_DT ratio_NN of_IN viral_JJ RNA_NP to_TO the_DT amount_NN of_IN Gag_NP from_IN VLPs_NP (_( see_VB Materials_NNS and_CC Methods_NNS for_IN details_NNS )_) ._SENT The_DT RNA_NP packaging_NN efficiency_NN with_IN wild-type_NN BLV_NP NC_NP was_VBD set_VBN at_IN 100_CD ,_, and_CC the_DT values_NNS for_IN the_DT NC_NP mutants_NNS (_( +-_NN standard_NN deviation_NN )_) are_VBP relative_JJ to_TO that_DT of_IN the_DT wild_JJ type_NN (_( WT_NP )_) ._SENT Mutants_NNS were_VBD tested_VBN in_IN parallel_NN with_IN the_DT parental_JJ construct_NN ,_, and_CC each_DT experiment_NN was_VBD done_VBN in_IN triplicate_NN ._SENT Mutagenesis_NN of_IN basic_JJ residues_NNS in_IN the_DT BLV_NP MA_NN domain_NN of_IN PrGag_NP results_NNS in_IN RNA_NP packaging_NN defects_NNS ._SENT Mutagenesis_NN of_IN basic_JJ residues_NNS in_IN the_DT BLV_NP MA_NN domain_NN of_IN PrGag_NP results_NNS in_IN RNA_NP packaging_NN defects_NNS ._SENT (_( A_NP )_) The_DT BLV_NP MA_NN domain_NN of_IN PrGag_NP ._SENT Amino_NN acid_NN residues_NNS in_IN boldface_JJ indicate_VBP basic_JJ residues_NNS ,_, and_CC boldface_JJ residues_NNS that_WDT are_VBP underlined_VBN indicate_VBP basic_JJ and/or_CC charged_JJ residues_NNS conserved_VBN among_IN BLV_NP ,_, HTLV-1_NP ,_, and_CC HTLV-2_NP ._SENT The_DT alpha-helices_NNS in_IN MA_NNS are_VBP indicated_VBN ,_, based_VBN upon_IN nuclear_JJ magnetic_JJ resonance_NN solution_NN structure_NN analysis_NN of_IN BLV_NP MA_NP ._SENT (_( B_NP )_) Quantitation_NP of_IN VLP_NP production_NN ._SENT Preparation_NN of_IN lysates_NNS from_IN VLP-producing_JJ cells_NNS and_CC VLPs_NNS and_CC immunoblot_NN analysis_NN are_VBP described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT Representative_JJ results_NNS from_IN the_DT immunoblot_NN analysis_NN are_VBP shown_VBN ._SENT WT_NP ,_, wild_JJ type_NN ._SENT (_( C_NP )_) Linear_NP range_NN of_IN detection_NN for_IN immunoblot_NN analysis_NN ._SENT Protein_NN was_VBD diluted_VBN (_( 1:1_CD ,_, 1:2_CD ,_, 1:4_CD ,_, 1:5_CD ,_, 1:8_CD ,_, 1:10_CD ,_, and_CC 1:16_CD )_) and_CC was_VBD subjected_VBN to_TO immunoblot_NN analysis_NN ._SENT The_DT band_NN intensity_NN (_( arbitrary_JJ units_NNS )_) for_IN each_DT dilution_NN was_VBD determined_VBN with_IN the_DT Quantity_NP One_CD software_NN package_NN of_IN the_DT Chemi_NP Doc_NP 2000_CD Documentation_NP System_NP (_( Bio-Rad_NP )_) and_CC plotted_VBD against_IN the_DT amount_NN of_IN protein_NN used_VBN for_IN immunoblot_NN analysis_NN (_( 16_CD ,_, 8_CD ,_, 4_CD ,_, 3.2_CD ,_, 2_CD ,_, 1.6_CD ,_, or_CC 1_CD mul_NN )_) to_TO determine_VB if_IN protein_NN detection_NN within_IN the_DT dilution_NN range_NN was_VBD linear_JJ ._SENT (_( D_NP )_) Relative_NP RNA_NP packaging_NN efficiencies_NNS of_IN BLV_NP MA_NP mutants_NNS ._SENT RNA_NP packaging_NN efficiencies_NNS were_VBD determined_VBN by_IN the_DT ratio_NN of_IN viral_JJ RNA_NP to_TO the_DT amount_NN of_IN Gag_NP from_IN VLPs_NP (_( see_VB Materials_NNS and_CC Methods_NNS for_IN details_NNS )_) ._SENT The_DT RNA_NP packaging_NN efficiency_NN with_IN wild-type_NN BLV_NP MA_NP was_VBD set_VBN at_IN 100_CD ,_, and_CC the_DT values_NNS for_IN the_DT MA_JJ mutants_NNS (_( +-_NN standard_NN deviation_NN )_) are_VBP relative_JJ to_TO that_DT for_IN the_DT wild_JJ type_NN ._SENT Mutants_NNS were_VBD tested_VBN in_IN parallel_NN with_IN the_DT parental_JJ construct_NN ,_, and_CC each_DT experiment_NN was_VBD done_VBN in_IN triplicate_NN ._SENT (_( E_NP )_) Cellular_NP distribution_NN of_IN PrGag_NP for_IN selected_JJ MA_JJ mutants_NNS ._SENT Cells_NNS stably_RB transfected_VBN with_IN VLP_NP constructs_NNS containing_VBG mutations_NNS in_IN MA_NP were_VBD grown_VBN on_IN coverslips_NNS ,_, fixed_VBN ,_, and_CC incubated_VBD with_IN an_DT anti-HA_NP Ig_NP followed_VBD by_IN incubation_NN with_IN Alexa_NP Fluor_NP 488-conjugated_JJ antimouse_NN Ig_NP ._SENT Images_NNS were_VBD obtained_VBN with_IN a_DT confocal_JJ microscope_NN ._SENT Requirement_NN of_IN charged_VBN amino_NN acid_NN residues_NNS in_IN BLV_NP MA_NP for_IN RNA_NP packaging_NN ._SENT Requirement_NN of_IN charged_VBN amino_NN acid_NN residues_NNS in_IN BLV_NP MA_NP for_IN RNA_NP packaging_NN ._SENT RNA_NP packaging_NN efficiencies_NNS were_VBD determined_VBN by_IN the_DT ratio_NN of_IN viral_JJ RNA_NP to_TO the_DT amount_NN of_IN Gag_NP from_IN VLPs_NP (_( see_VB Materials_NNS and_CC Methods_NNS for_IN details_NNS )_) ._SENT The_DT RNA_NP packaging_NN efficiency_NN with_IN wild-type_NN (_( WT_NP )_) BLV_NP MA_NP was_VBD set_VBN at_IN 100_CD ,_, and_CC the_DT values_NNS for_IN the_DT MA_JJ mutants_NNS (_( +-_NN standard_NN deviation_NN )_) are_VBP relative_JJ to_TO that_DT for_IN the_DT wild_JJ type_NN ._SENT (_( A_NP )_) Mutants_NP were_VBD tested_VBN in_IN parallel_NN with_IN the_DT parental_JJ construct_NN ,_, and_CC each_DT experiment_NN was_VBD done_VBN in_IN triplicate_NN ._SENT (_( B_NP )_) Cellular_NP distribution_NN of_IN PrGag_NP ._SENT Cells_NNS stably_RB transfected_VBN with_IN VLP_NP constructs_NNS were_VBD grown_VBN on_IN coverslips_NNS ,_, fixed_VBN ,_, and_CC incubated_VBN with_IN antibodies_NNS prior_RB to_TO confocal_JJ microscopy_NN ._SENT Combined_JJ influence_NN of_IN NC_NP and_CC MA_JJ mutations_NNS on_IN RNA_NP packaging_NN ._SENT Combined_JJ influence_NN of_IN NC_NP and_CC MA_JJ mutations_NNS on_IN RNA_NP packaging_NN ._SENT RNA_NP packaging_NN efficiencies_NNS were_VBD determined_VBN by_IN the_DT ratio_NN of_IN viral_JJ RNA_NP to_TO the_DT amount_NN of_IN Gag_NP from_IN VLPs_NP (_( see_VB Materials_NNS and_CC Methods_NNS for_IN details_NNS )_) ._SENT The_DT RNA_NP packaging_NN efficiency_NN with_IN wild-type_NP BLV_NP was_VBD set_VBN at_IN 100_CD ,_, and_CC the_DT values_NNS for_IN the_DT mutants_NNS (_( +-_NN standard_NN deviation_NN )_) are_VBP relative_JJ to_TO that_DT for_IN the_DT wild_JJ type_NN (_( WT_NP )_) ._SENT Mutants_NNS were_VBD tested_VBN in_IN parallel_NN with_IN the_DT parental_JJ construct_NN ,_, and_CC these_DT experiments_NNS were_VBD done_VBN in_IN triplicate_NN ._SENT Lack_NN of_IN transient_JJ nuclear_JJ localization_NN of_IN BLV_NP Gag_NP ._SENT Lack_NN of_IN transient_JJ nuclear_JJ localization_NN of_IN BLV_NP Gag_NP ._SENT 293T_JJ cells_NNS were_VBD transiently_RB transfected_VBN alone_RB with_IN an_DT RSV_NP Gag-GFP_NP construct_NN or_CC a_DT BLV_NP vector_NN (_( PR+_NP )_) and_CC treated_VBN with_IN LMB_NP (_( 10_CD ng/mul_NNS )_) or_CC were_VBD transiently_RB cotransfected_JJ with_IN the_DT RSV_NP or_CC BLV_NP construct_NN and_CC a_DT dominant-negative_JJ CRM1_NP (_( DeltaCAN_NP )_) (_( 10_CD mug_NN per_IN approximately_RB 5_CD x_NN 105_CD cells_NNS )_) ._SENT In_IN parallel_NN ,_, FLK_NP cells_NNS chronically_RB infected_VBN with_IN BLV_NP were_VBD treated_VBN with_IN LMB_NP (_( 10_CD ng/mul_NNS )_) or_CC were_VBD transiently_RB transfected_VBN with_IN DeltaCAN_NP (_( 10_CD mug_NN per_IN approximately_RB 5_CD x_NN 105_CD cells_NNS )_) ._SENT Forty-eight_NP hours_NNS posttransfection_NN ,_, cells_NNS were_VBD fixed_VBN and_CC then_RB analyzed_VBN by_IN confocal_JJ microscopy_NN ._SENT 